Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05525806 · ClinicalTrials.gov registry record · NA
Clinical Utility Study for MyProstateScore+
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 234
- Enrollment target
NCT05525806: Completed NA study, sponsored by Qure Healthcare.
NCT05525806 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 234 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05525806, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 234 participants
- Enrollment target
Study Summary
This is a national-level research study of urologists. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
Primary Outcome
Measuring the rates of ordering prostate biopsy with proper assessment, recognition, and management of prostate cancer risks in patients with different PSA levels, a negative previous prostate biopsy, and an elevated PI-RADS score.
Interventions
- OTHER Education Materials for MyProstateScore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2023-06-04 |
| Phase | NA |
What the finished NCT05525806 record still lists
NCT05525806 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Education Materials for MyProstateScore is the first listed.
NCT05525806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05525806 about?
NCT05525806 is a clinical study titled "Clinical Utility Study for MyProstateScore+". This is a national-level research study of urologists. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
What is the current status of trial NCT05525806?
This trial is currently completed. It is a NA study. The enrollment target is 234 participants. The study started on 2022-09-12. Estimated completion is 2023-06-04.
What interventions are being tested in trial NCT05525806?
The interventions under investigation include: Education Materials for MyProstateScore (OTHER).
Who is sponsoring clinical trial NCT05525806?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05525806's enrollment target sits among peer trials
234 462nd of 2000 higher than 1,538 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI